180 Life Sciences
ATNF
trading on NASDAQ
since 2017
180 Life Sciences specializes in developing innovative therapeutic solutions for patients with serious conditions in oncology and rare diseases.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $5.98 | $12.74 | $4.88 | $459.10M | 218.51M |
| eps | p/e | p/s |
operating margin |
profit margin |
yield |
| -$0.30 | n/a | +Inf | -Inf% | -Inf% | 0% |